BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia

BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion

Published:2023-06 Issue: Volume:119 Page:110201
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Guo Kongwei^ORCID,Shang Yanxing,Wang Zhao,Li Yu,Chen Jinliang,Zhu Baofeng,Zhang Dongmei,Chen Jianrong^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference46 articles.

1. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association;Virani;Circulation,2021

2. Ischemic neuronal damage;Taoufik;Curr Pharm Des,2008

3. Xu H, Wang E, Chen F, Xiao J, Wang M. Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications. Oxid Med Cell Longev. 2021 28;2021:6687386. doi: 10.1155/2021/6687386.

4. Monsour M, Croci DM, Agazzi S, Borlongan CV. Getting the guts to expand stroke treatment: The potential for microbiome targeted therapies. CNS Neurosci Ther. 2022 10. doi: 10.1111/cns.13988.

5. Management of Acute Ischemic Stroke;Herpich;Crit Care Med,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation, identification and molecular docking of two novel anti-aging peptides from perilla seed;Heliyon;2024-07

2. BRG1 Deficiency Promotes Cardiomyocyte Inflammation and Apoptosis by Activating the cGAS-STING Signaling in Diabetic Cardiomyopathy;Inflammation;2024-06-13

3. Research progress of prodrugs for the treatment of cerebral ischemia;European Journal of Medicinal Chemistry;2024-06

4. Benzoylaconine Protects Skeletal Muscle Against Ischemia-Reperfusion Injury Through Activation of IF1-Dependent AMPK/Nrf2 Axis;Drug Design, Development and Therapy;2024-06

5. Corrigendum to “BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion” [Int. Immunopharmacol. 119 (2023) 110201];International Immunopharmacology;2024-03